SitNews - Stories in the News - Ketchikan, Alaska

Alaska Attorney General alleges fraudulent distribution by opioid manufacturer Mallinckrodt

 

January 31, 2019
Thursday PM


(SitNews) Anchorage, Alaska - As part of the State’s ongoing efforts in battling Alaska’s opioid crisis, Attorney General Kevin G. Clarkson filed a lawsuit this week against opioid manufacturer Mallinckrodt PLC, Mallinckrodt LLC and SpecGX LLC, a Mallinckrodt subsidiary.

Northway Family Healthcare - Ketchikan, Alaska

Davies-Barry Insurance - Ketchikan, Alaska

The lawsuit filed Tuesday alleges that for more than a decade, Mallinckrodt engaged in a deceptive marketing campaign that minimized the risks of opioids, especially the serious risks of addiction, and sought to convince doctors that there was a significant upside to their use for chronic pain by exaggerating their purported benefits. The State alleges these claims are unsupported by the scientific evidence and were, and remain, too often fatally false. The State claims that Mallinckrodt relayed, and continues to relay, its deceptive messages to prescribers, which it has spread through marketing materials, websites, and in-person sales calls. The suit also describes how the company relied upon and sponsored speakers’ programs, professional associations, and third-party groups (Front Groups) that disseminated its misleading messages while appearing independent and therefore credible.

Based on prescriptions, Mallinckrodt is the largest manufacturer of opioids in the United States, and in 2015 estimated that it accounted for 25 percent of the Drug Enforcement Administration’s (DEA) entire annual quota for controlled substances that it manufacturers.

“It is no secret that Alaska has been hit hard by the opioid epidemic, and we don’t have time to lose,” said Attorney General Kevin G. Clarkson. “My office is dedicated to taking all appropriate steps to hold accountable those who violate the law and jeopardize our public health and safety.”

The State’s complaint alleges Mallinckrodt has violated, and continues to violate, the Alaska Unfair Trade Practices and Consumer Protection Act (UTPA). The lawsuit also asserts that Mallinckrodt’s unlawful conduct has created a public nuisance, that Mallinckrodt has acted fraudulently and negligently, and that Mallinckrodt has been unjustly enriched and is strictly liable for its actions.  

On October 25, 2018, the Attorney General’s Office filed a lawsuit against opioid distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Company. That lawsuit alleges that the three companies disregarded their obligations under Alaska law to report and halt suspicious orders and prevent diversion of prescription drugs.

On October 30, 2017, the Attorney General’s Office filed a lawsuit against Purdue Pharma, L.P. and its corporate family, the maker of OxyContin. The suit alleges that Purdue used deceptive practices in violation of state consumer protection laws, by, among other things, deceptively misrepresenting the risk that patients would become addicted to its opioids and overstating the benefits of the drugs. The Alaska Superior Court denied Purdue’s motions to dismiss the case on July 12, 2018. A trial date in this action has been set for March 23, 2020.

 

 

On the Web:

01/28/19 Alaska Dept. of Law Complaint PDF

 

 

Editing by Mary Kauffman, SitNews

 

Source of News:

Alaska Department of Law
www.law.state.ak.us

 

Representations of fact and opinions in comments posted are solely those of the individual posters and do not represent the opinions of Sitnews.



Submit A Letter to SitNews

Contact the Editor

SitNews ©2019
Stories In The News
Ketchikan, Alaska

 Articles & photographs that appear in SitNews are considered protected by copyright and may not be reprinted without written permission from and payment of any required fees to the proper freelance writers and subscription services.

E-mail your news & photos to editor@sitnews.us

Photographers choosing to submit photographs for publication to SitNews are in doing so granting their permission for publication and for archiving. SitNews does not sell photographs. All requests for purchasing a photograph will be emailed to the photographer.